Can you take Cangrelor with Plasminogen, human?
1 drug interaction and 1 additional warning found for the following 2 drugs:
- cangrelor
- plasminogen, human
Drug interactions
Major drug interactions
Major:
cangrelor plasminogen, human
Applies to: cangrelor and plasminogen, human
Using plasminogen, human together with cangrelor may increase the risk of bleeding.
Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications.
You should seek immediate medical attention if you experience any unusual bleeding or bruising or have other signs and symptoms of bleeding such as:
- dizziness
- lightheadedness
- red or black, tarry stools
- coughing up or vomiting fresh or dried blood that looks like coffee grounds
- severe headache
- weakness
It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Food/lifestyle interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Disease interactions
1 potential interaction Applies to: 1 condition, including Bleeding Disorder.
Bleeding Disorder
Major:
cangrelor
Cangrelor has a major potential interaction with Bleeding Disorder.
Cangrelor is contraindicated in patients with significant active bleeding.
More resources
cangrelor
A total of 155 drugs are known to interact with cangrelor.
- Cangrelor is in the drug class platelet aggregation inhibitors.
- Cangrelor is used to treat Percutaneous Coronary Intervention.
plasminogen, human
A total of 77 drugs are known to interact with plasminogen, human.
- Plasminogen, human is in the drug class miscellaneous uncategorized agents.
- Plasminogen, human is used to treat Hypoplasminogenemia.
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.